Cansortium Inc. (OTCMKTS:CNTMF – Get Free Report) saw a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 208,442 shares, an increase of 370.1% from the May 14th total of 44,344 shares. Based on an average trading volume of 516,366 shares, the days-to-cover ratio is currently 0.4 days.
Cansortium Stock Down 7.9%
Shares of CNTMF stock opened at $0.02 on Thursday. The stock has a 50-day moving average of $0.03 and a 200-day moving average of $0.04. Cansortium has a one year low of $0.02 and a one year high of $0.09.
Cansortium (OTCMKTS:CNTMF – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported ($0.16) EPS for the quarter. During the same quarter in the prior year, the company earned ($0.14) earnings per share.
About Cansortium
Cansortium, Inc (OTCMKTS:CNTMF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing, distribution and retail of medical cannabis products in the United States. The company’s operations span from seed to sale, with dedicated cultivation facilities, extraction labs and a network of dispensaries serving registered patients.
Cansortium holds licenses and operates in multiple jurisdictions, including Florida, Pennsylvania, Louisiana, Texas and Puerto Rico. Its product portfolio encompasses cannabis flower, pre-rolls, concentrates, vape cartridges, oils, edibles and topicals, offered under brands such as The+Source, Chroma and Campfire, alongside its private-label formulations.
Founded in 2017 and headquartered in Miami, Cansortium began dispensary operations in Florida in 2018 and has since expanded its footprint into new markets.
Featured Stories
- Five stocks we like better than Cansortium
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Cansortium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cansortium and related companies with MarketBeat.com's FREE daily email newsletter.
